The patented method uses genetic markers and a weighted algorithm to assess the responsiveness to renal denervation.

On Thursday, the US Centers for Medicare & Medicaid Services (CMS) issued its proposal for covering radiofrequency- or ...

Analysts are optimistic about Medtronic (MDT) after the Centers for Medicare and Medicaid Services (CMS) proposed to cover ...

About the Paradise Ultrasound Renal Denervation System The Paradise uRDN system is a first-of-its-kind ultrasound-based RDN ...

Medtronic is studying the use of its nitinol-enabled Symplicity Spyral renal denervation (RDN) catheter combined with hepatic ...

Medtronic and Recor Medical both issued statements supporting new Medicare coverage for their respective renal denervation ...

Medtronic reported that it has begun testing an expansion of its renal denervation approach for dropping stubbornly high blood pressure, by also treating vessels outside of the kidneys.&n | The ...

CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward ...

Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), today announced their support for ...

While the use of renal denervation in the USA is currently restricted to trials, in Europe, the pressure put by marketers on interventional cardiologists and radiologists will likely contribute to ...

Medtronic, Inc. (NYSE:MDT) ranks among the top stocks for an early retirement portfolio. On June 18, RBC Capital reiterated a $101 price target and an Outperform rating on Medtronic, Inc. (NYSE:MDT), ...

In the meantime, renal denervation should remain the ultima ratio in adherent and truly resistant patients with severe hypertension, confirmed by ambulatory monitoring, in whom secondary ...